Marin Biologic Laboratories

Executive Summary

Marin Biologic Laboratories (MarinBio) is a privately held Contract Research Organization (CRO) based in San Rafael, California, with over 30 years of experience in custom bioanalytical assay development and validation. The company supports drug discovery and development from research to commercialization, offering GMP/GLP-compliant assays for IND and BLA submissions. Its expertise includes cell-based assays, immunoassays, molecular biology, and targeted services for advanced modalities such as cell and gene therapy. By providing high-quality, regulatory-compliant services, MarinBio serves as a critical partner for pharmaceutical and biotechnology companies seeking to accelerate their drug development pipelines. The company's established reputation and long-standing presence in the industry position it well within the growing CRO market, driven by increasing R&D outsourcing trends. However, as a private firm, detailed financial and operational metrics are not publicly available, and growth prospects depend on client acquisitions and capacity expansion. The company's focus on niche, high-complexity assays may provide competitive advantages but also limits scalability. Overall, MarinBio represents a stable, specialized service provider in the bioanalytical CRO space.

Upcoming Catalysts (preview)

• Q3 2026Expansion of cell and gene therapy assay services70% success
• Q4 2026Securing a major pharmaceutical outsourcing contract50% success
• Q2 2026Completion of facility expansion for increased GLP capacity80% success